Skip to main navigation Skip to search Skip to main content

When can the infusion period be safely ignored in the estimation of pharmacokinetic parameters of drugs in humans?

  • L. S. Freedman
  • , P. Workman
  • Medical Research Council

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Abstract

We describe a simple and rapid method to determine the amount by which the area under the curve (AUC) is underestimated when a drug is given by i.v. infusion but the infusion period is ignored and the post-infusion data are analysed as if they derive from a bolus injection. Charts are provided that allow the investigator to determine the approximate underestimation for drugs following the one- and two-compartment models, and hence to decide whether it is acceptable to ignore the infusion period in a given case (e.g., underestimation < 5% or 10%). Equations are also provided that allow the exact underestimation to be calculated, together with the true value of the AUC.

Original languageEnglish
Pages (from-to)95-103
Number of pages9
JournalCancer Chemotherapy and Pharmacology
Volume22
Issue number2
DOIs
StatePublished - Aug 1988
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'When can the infusion period be safely ignored in the estimation of pharmacokinetic parameters of drugs in humans?'. Together they form a unique fingerprint.

Cite this